BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16033375)

  • 1. Comment on 'What is the direct cost of treatment of acute primary angle closure glaucoma? The Singapore model'.
    Papalkar D; Francis IC; Lim R
    Clin Exp Ophthalmol; 2005 Aug; 33(4):446; author reply 447. PubMed ID: 16033375
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the direct cost of treatment of acute primary angle closure glaucoma? The Singapore model.
    Wang JC; Chew PT
    Clin Exp Ophthalmol; 2004 Dec; 32(6):578-83. PubMed ID: 15575827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic considerations of the diagnosis and management for glaucoma in the developed world.
    Tuulonen A
    Curr Opin Ophthalmol; 2011 Mar; 22(2):102-9. PubMed ID: 21192264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glaucoma care cost-effectiveness.
    Hoskins HD
    Ophthalmology; 2009 May; 116(5):1016. PubMed ID: 19410965
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
    Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR;
    J Glaucoma; 2007 Aug; 16(5):471-8. PubMed ID: 17700290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness: insights on treatment options for open-angle glaucoma.
    Morse AR; Lee PP
    Arch Ophthalmol; 2012 Apr; 130(4):506-7. PubMed ID: 22491919
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute primary angle closure-treatment strategies, evidences and economical considerations.
    Chan PP; Pang JC; Tham CC
    Eye (Lond); 2019 Jan; 33(1):110-119. PubMed ID: 30467424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations in developing model-based economic evaluations of glaucoma treatment.
    Althin R; Grima DT; Dhawan R; Bernard LM
    J Glaucoma; 2006 Dec; 15(6):541-7. PubMed ID: 17106369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of glaucoma care provided to Medicare beneficiaries from 2002 to 2009.
    Quigley HA; Cassard SD; Gower EW; Ramulu PY; Jampel HD; Friedman DS
    Ophthalmology; 2013 Nov; 120(11):2249-57. PubMed ID: 23769330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared Cared for Stable Glaucoma Patients: Economic Benefits and Patient-centered Outcomes of a Feasibility Trial.
    Goh D; de Korne DF; Ho H; Mathur R; Chakraborty B; Van Hai N; Wai C; Perera S; Aung T; Wong TY; Lamoureux EL
    J Glaucoma; 2018 Feb; 27(2):170-175. PubMed ID: 29271805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucoma: where to now?
    Taylor HR
    Ophthalmology; 2009 May; 116(5):821-2. PubMed ID: 19410940
    [No Abstract]   [Full Text] [Related]  

  • 13. Economic impact of primary open-angle glaucoma in Australia.
    Dirani M; Crowston JG; Taylor PS; Moore PT; Rogers S; Pezzullo ML; Keeffe JE; Taylor HR
    Clin Exp Ophthalmol; 2011; 39(7):623-32. PubMed ID: 21631669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current management options in primary angle closure disease.
    Krishnadas R
    Indian J Ophthalmol; 2019 Mar; 67(3):321-323. PubMed ID: 30777944
    [No Abstract]   [Full Text] [Related]  

  • 15. Costs of a community-based glaucoma detection programme: analysis of the Philadelphia Glaucoma Detection and Treatment Project.
    Pizzi LT; Waisbourd M; Hark L; Sembhi H; Lee P; Crews JE; Saaddine JB; Steele D; Katz LJ
    Br J Ophthalmol; 2018 Feb; 102(2):225-232. PubMed ID: 28655730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma Care.
    Fukuda Y; Kume A; Kashiwagi K
    Curr Eye Res; 2021 Nov; 46(11):1695-1702. PubMed ID: 33843390
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes of combined lens extraction and goniosynechialysis in angle closure.
    White AJ; Orros JM; Healey PR
    Clin Exp Ophthalmol; 2013 Nov; 41(8):746-52. PubMed ID: 23601286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glaucoma Control Strategies in Sub-Saharan Africa: A Review of the Clinical and Health Economic Evidence.
    Smith AF; Negretti G; Mascaro A; Bokre D; Baker H; Dhalla K; Murdoch IE
    Ophthalmic Epidemiol; 2018; 25(5-6):419-435. PubMed ID: 30059637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.
    Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
    Am J Manag Care; 2011 Sep; 17(9):e365-74. PubMed ID: 21902444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of acute angle-closure glaucoma in Dalmatia, southern Croatia.
    Bojić L; Mandić Z; Ivanisević M; Bucan K; Kovacević S; Gverović A; Miletić-Jurić A
    Croat Med J; 2004 Jun; 45(3):279-82. PubMed ID: 15185417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.